Patents by Inventor Jeanne Moody

Jeanne Moody has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MAGL inhibitors
    Patent number: 11434222
    Abstract: Provided herein are substituted 1,1,1,3,3,3-hexafluoropropan-2-yl 6-azaspiro[2.5]octane-6-carboxylate compounds and pharmaceutical compositions comprising said compounds. The compounds and compositions provided herein are useful as inhibitors of MAGL. Furthermore, the compounds and compositions as provided herein are useful for the treatment of diseases and disorders benefiting from the inhibition of MAGL.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: September 6, 2022
    Assignee: H. LUNDBECK A/S
    Inventors: John J. M. Wiener, Cheryl A. Grice, Daniel J. Buzard, Justin S. Cisar, Olivia Delene Weber, Amy Allan, Nicholas Raffaele, Jeanne Moody, Michael B. Shaghafi
  • MAGL INHIBITORS
    Publication number: 20220153721
    Abstract: Provided herein are substituted 1,1,1,3,3,3-hexafluoropropan-2-yl 6-azaspiro[2.5]octane-6-carboxylate compounds and pharmaceutical compositions comprising said compounds. The compounds and compositions provided herein are useful as inhibitors of MAGL. Furthermore, the compounds and compositions as provided herein are useful for the treatment of diseases and disorders benefiting from the inhibition of MAGL.
    Type: Application
    Filed: November 11, 2021
    Publication date: May 19, 2022
    Inventors: John J.M. WIENER, Cheryl A. GRICE, Daniel J. BUZARD, Justin S. CISAR, Olivia Delene WEBER, Amy ALLAN, Nicholas RAFFAELE, Jeanne MOODY, Michael B. SHAGHAFI
  • Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
    Publication number: 20070254903
    Abstract: The invention provides compounds of Formula (I): and pharmaceutically acceptable salts, solvates and stereoisomers thereof, wherein A, B, E, G, W, X, Y, Z, o, and R1 are as disclosed herein (“Compound(s) of the Invention”), which are useful as cardio-protective and/or neuro-protective agents. The invention also provides pharmaceutical compositions comprising a Compound of the Invention and methods for treating, preventing and/or managing a vascular, cardiovascular or neurological disease or disorder, comprising administering to a patient in need thereof a Compound of the Invention.
    Type: Application
    Filed: December 22, 2004
    Publication date: November 1, 2007
    Applicant: ARENA PHARMACEUTICALS, INC.
    Inventors: P. Boatman, John Adams, Jeanne Moody, Eric Babych, Thomas Schrader